What is LOPJLB’s current signal on RAPT?

LOPJLB’s latest quantitative signal on RAPT Therapeutics, Inc. (RAPT) is BUY in a BULL regime. Signals are updated daily.

What market regime is RAPT in?

RAPT Therapeutics, Inc. (RAPT) is currently classified in the BULL HMM market regime on LOPJLB.

What does RAPT Therapeutics, Inc. (RAPT) do?

RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical firm specializing in immunology. The company is dedicated to discovering, developing, and commercializing innovative oral small molecule therapies. These treatments are aimed at addressing critical unmet medical needs for patients battling oncology and inflammatory diseases. Its primary drug candidate for inflammation, RPT193, functi…

Where is RAPT Therapeutics, Inc. based / listed?

RAPT Therapeutics, Inc. is based in US, listed on NASDAQ.

RAPT Therapeutics, Inc. (RAPT) Stock · BUY · BULL

Key stats

Market cap: $959M
Avg volume: 2.3M

Beta: 0.44
P/E (TTM): -29.87

1W: +0.05%
1M: +0.40%
3M: +80.77%
YTD: +82.14%

vs SPY 1W: +1.24%
vs SPY 1M: -2.92%
vs SPY 3M: +78.38%
vs SPY YTD: +70.38%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Sector peers

Industry peers

Prediction markets

Company news